Thursday, January 26, 2017 8:44:49 AM
the reality is, we are not selling 1 million patches this year, however...we don't need to.
The company needs to stop dilution, and then first cover expenses for the next version of the "medicated" patch.
If they can get that developed and approved quickly, they will be perceived as a legitimate pharmacuetical company.
Then they can continue their work on the cancer treatments.
If they can generate the funding to go full steam ahead with that,
things will get very interesting here.
That is when we may start to see dollars here.
Point is, any longs here will have to very patient.
Just my thoughts....have fun!
-CC
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM